R/M about to go back to fully reporting as Biotech, easy billion dollar market cap coming to it. I think it will do an SEC 1-A uplist to NYSE and run past $100/share based on my DD
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.